fingolimod hydrochloride has been researched along with Mycosis Fungoides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Che, Y; Kim, YH; Lock, CB; Narala, S; Rieger, KE; Saleem, A | 1 |
| Appel, S; Kucuk, N; Milo, R; Nitsan, Z; Osherov, M; Tichmanovich, N | 1 |
2 other study(ies) available for fingolimod hydrochloride and Mycosis Fungoides
| Article | Year |
|---|---|
Progression of Mycosis Fungoides After Fingolimod Treatment for Multiple Sclerosis and Targeted Next-Generation Sequencing Demonstrating Potential Links Between the Two Diseases.
Topics: Fingolimod Hydrochloride; High-Throughput Nucleotide Sequencing; Humans; Multiple Sclerosis; Mycosis Fungoides; Skin Neoplasms | 2023 |
Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis.
Topics: Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Mycosis Fungoides; Skin; Skin Neoplasms; Treatment Outcome | 2018 |